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Conclusions: 1) ICP use is steadily increasing in MI pts ineligible for TTX
in Israel; 2) increased ICP rates are associated with decrease of early death
among M I patients ineligible for TTX.
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In the reperfusion era thrombolytic trials reported a "smoker's paradox" in
which a favorable clinical outcome was noted in smokers. This was thought
to be due in part to the hypercoagulable state with smoking, resulting in a
more thrombotic coronary occlusion which responds well to thrombolysis.
To determine whether the type of reperfusion strategy affects outcome in
smokers vs. nonsmokers, we evaluated 395 patients (pts) who were random-
ized to tPA vs. primary PTCA in the PAMI study of whom 168 were smokers
(SM) and 128 never smoked INS). The combined in-hospital outcome includ-
ing death, recurrent MI or recurrent ischemia was similar in SM and NS (p
= 0.12) despite univariate analysis revealing that SM were younger (65 vs.
55 yrs, p < 0.001) and less likely to be female (20 vs. 41%, P < 0.001) com-
pared with NS. Stratifying the data according to reperfusion modality, smok-
ers treated with tPA did significantly better than NS (p = 0.041; a difference
that did not exist in the PTCA group (SM vs NS, p = 0.69). Multivariate anal-
ysis revealed that NS treated with PTCA had less recurrent ischemia (11 vs.
33%, p ~ 0.004) and combined mortality or recurrent MI (7 vs 18%, P =
0.05) compared with those treated with tPA. At 6 months, NS treated with
PTCA vs. tPA continued to have fewer deaths or recurrent MI. (11 vs. 24%,
P = 0.07). Conversely, treatment strategy in SM did not significantly affect
hospital outcomes; recurrent ischemia (12 vs. 23%, P = 0.07) and mortality
combined with recurrent MI (6 vs. 8%, P = 0.55) in PTCA and tPA groups. The
statistical significance of these associations is maintained when controlling
for age and gender.
Conclusion: Nonsmokers presenting with acute MI have a significantly bet-
ter outcome after treatment with primary angioplasty. Even when controlling
for age and gender the reperfusion strategy affects outcome in NS, a differ-
ence not seen in SM. These data add further support to the hypothesis that
nonsmokers have a more atherosclerotic occlusion which may explain why
they benefit from primary angioplasty more than thrombolysis.
ST elevation MI (n = 94):
Age 2: 75 yrs (n ~ 78):
Onset ~ 12 hrs (n = 1631:
Chronic angina (n = 114):
Chronic CHF In = 51):
Prior MI (n = 108):
Hospital death (n ~ 28):
The most common reason for not treating with n was absence of criteria
for ST elevation MI in 179/222 pts 181 %). Of 35/222 (16%) who presented
between 4-12 hrs, age or duration of symptoms was the sole contraindica-
tion to n in only 8 (4%). Other less common major contra indications to TT
included prolonged chest massage, recent surgery, active internal bleeding,
and hemodynamic instability. Conclusions: 1) Most pts did not receive n.
2) Even with expanded treatment criteria, few additional pts become can-
didates for n. 3) Future research should focus on the majority of the MI
population which fails to meet ECG or other n criteria.
Thrombolytic therapy In) clearly saves lives in acute myocardial infarction
IMI). but the major limitation to its widespread use has been the large propor-
tion of M I pts considered ineligible for n. In recent overviews of the large
randomized n trials, net benefit is consistently seen with: 1) ST elevation
Mlldiagnostic ST elevations in any anatomic location) or left bundle branch
block on presenting ECG; 2) any age; and 3) onset of symptoms < 12 hrs.
To describe correlates of n utilization and to determine the potential impact
of recently expanded n criteria on the number of untreated pts, we studied
292 pts with acute MI who were admitted via the Emergency Department
between June 1991 and December 1992 into a large university teaching hos-
pital.
Results: 222 (76%) did not receive n. Univariate correlates of n utilization:
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In order to determine whether expanding use of thrombolytic therapy (n)
has influenced overall acute myocardial infarction (AMI) outcome, we eva 1-
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Characteristics (%) 1990 (n = 267) 1992 In ~ 546) 1992 In ~ 567)
Men 68 75 69
Age (mean + SO) 65±11yrs 65± 12yrs 65± 12yrs
>75 yrs 21 25 22
First MI 66 63 60
ICP(%)
Coronaro-angiography 15 18 27
PTCA <1 6 11
CABG <1 2 5
Mortality (%) 13 10 8
17 days)
We also instituted this AMI team approach in three area small town rural
hospitals to see if this approach would be beneficial in this setting. Similar
reductions in time to treatment were observed.
Conclusion: 1) AMI team approach effectively lowers time to treatment
in large medical center hospitals and in small town rural hospitals; 2) wide-
spread use of this concept could significant lower mortality from ST segment
elevation AMI in the United States.
vs. other) was the only variable predicting mortality. Age was not a predictive
factor using univariate analysis; using multivariate analysis there was a trend
towards increasing mortality with age, which did not reach statistical signif-
icance. We conclude advanced age is not invariably associated with a fatal
outcome in acute infarction patients with cardiogenic shock and encourage
consideration of infarct angioplasty in patients presenting with shock regard-
less of patient age.
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In the United States, the average time between a patient's arrival in the emer-
gency room (ER) and the administration of thrombolytic therapy for ST ele-
vation and acute myocardial infarction (AMI) is over one hour. If the time to
treatment (Rx) after arrival in the ER could be reduced by 30 minutes, it has
been estimated that at least 5,000 lives could be saved annually in the United
States. In our institution, the average time to Rx after arrival in the ER for ST
elevation AMI from June 1991 to June 1993 was 71 ± 32 minutes Imedian
64 minutes). We then developed an "AMI team" approach which included
ER physicians, ER nurses, ECG technicians, and pharmacists. The diagnos-
tic approach of the AMI team was based on two pocket cards that contained
information on the following: 1) indicationslcontraindications of thrombolytic
treatment in AMI; 2) thrombolytic treatment drug selection guidelines ItPA
versus SK); 31 ancillary therapy drugs and dosages; and 4) ancillary therapy
indications/contraindications. Treatment by the AMI team centered around
an AMI kit-a tackle box that contained both thrombolytic drugs, all necessary
ancillary treatments (ASA. heparin, beta blockers, nitrates, MS, and magne-
sium) and IVtubing plus drug compatibility charts The time to Rx before and
after institution of the AMI team was as follows:
Patients (pts) with acute myocardial infarction (AMII ineligible for throm-
bolytic therapy (TTX) are at increased risk. Invasive coronary procedures (ICP)
have been recommended for these pts. In 3 surveys performed in the CCU's
of Israel during 1990, '92 and '94 the use of nx was 35, 46 and 43% respec-
tively. The characteristics and management of excluded pts from TTX in the
respective surveys were as follows:
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